GM Advisory Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,200
| Closed | -$218K | – | 125 |
|
|
2019
Q3 | $218K | Hold |
2,200
| – | – | 0.07% | 98 |
|
|
2019
Q2 | $203K | Hold |
2,200
| – | – | 0.06% | 105 |
|
|
2019
Q1 | $208K | Sell |
2,200
-2,984
| -58% | -$261K | 0.07% | 101 |
|
|
2018
Q4 | $332K | Hold |
5,184
| – | – | 0.12% | 70 |
|
|
2018
Q3 | $464K | Hold |
5,184
| – | – | 0.15% | 66 |
|
|
2018
Q2 | $412K | Hold |
5,184
| – | – | 0.12% | 74 |
|
|
2018
Q1 | $462K | Sell |
5,184
-120
| -2% | -$11.5K | 0.14% | 66 |
|
|
2017
Q4 | $554K | Buy |
5,304
+2,200
| +71% | +$248K | 0.15% | 64 |
|
|
2017
Q3 | $453K | Sell |
3,104
-104
| -3% | -$14.2K | 0.14% | 66 |
|
|
2017
Q2 | $417K | Buy |
3,208
+104
| +3% | +$12.7K | 0.13% | 72 |
|
|
2017
Q1 | $386K | Hold |
3,104
| – | – | 0.13% | 69 |
|
|
2016
Q4 | $359K | Buy |
+3,104
| New | +$346K | 0.13% | 77 |
|
|
2015
Q1 | – | Sell |
-2,664
| Closed | -$298K | – | 85 |
|
|
2014
Q4 | $298K | Sell |
2,664
-36
| -1% | -$3.8K | 0.16% | 47 |
|
|
2014
Q3 | $256K | Hold |
2,700
| – | – | 0.19% | 56 |
|
|
2014
Q2 | $232K | Buy |
+2,700
| New | +$205K | 0.2% | 61 |
|
|
2014
Q1 | – | Sell |
-2,710
| Closed | -$229K | – | 90 |
|
|
2013
Q4 | $229K | Buy |
+2,710
| New | +$214K | 0.24% | 55 |
|
Other funds holding CELG
GM Advisory Group's CELG Position: Q4 2019 in Review
GM Advisory Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,200 shares — an estimated $218K sold.
GM Advisory Group first reported a position in CELG in Q4 2013 and held it in 16 quarters. The position peaked at $554K in Q4 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- GM Advisory Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- GM Advisory Group sold 2,200 Celgene Corp shares in Q4 2019, an estimated $218K.
- GM Advisory Group first reported a position in Celgene Corp in Q4 2013 and held it in 16 quarters.
- GM Advisory Group's Celgene Corp position peaked at $554K in Q4 2017.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on GM Advisory Group's 13F filing for Q4 2019, filed 14 Feb 2020.